Borosil Q4 profit jumps; channel risk

1/ Borosil Scientific Ltd reported Q4 FY25 net profit of 272 million rupees ($3.25 million), up sharply from prior periods, with EBITDA margin hitting 22.43%.[^1] The Indian lab glassware maker disclosed results on May 20, 2026, via BSE filing, showing revenue growth amid a tough market.[^2] [^1]: [^2]: (Q4 results filing, May 20, 2026) 2/ Headline numbers: Revenue reached 1,822 million rupees, a 28% jump year-over-year, per the filing. Net profit swung from a 45 million rupee loss in Q4 FY24 to the 272 million gain. Volume growth in scientific glassware drove much of it, company statement said.[^3] [^3]: (Q4 FY25 press release) 3/ But here's the channel risk flagged by analysts: Physical laboratory glassware volumes slowed visibly, per distributor data cited in social commentary. Palwinder Singh CFA noted "deceleration in physical volumes" despite profit pop, warning of potential channel stuffing—pushing excess inventory to distributors to book sales.[^4] [^4]: 4/ Channel stuffing explained: Suppliers ship more product than distributors can sell, inflating quarterly revenue and profit. It masks weak end-demand. Later quarters face returns or write-downs. Borosil's 22.43% EBITDA margin looks pristine, but if volumes dipped, inventory pile-up at channels is suspect.[^5] [^5]: (analyst notes on inventory metrics) 5/ Evidence of slowdown? Borosil's own investor presentation showed lab glassware demand softening due to research funding cuts in India and globally. Imports from China undercut pricing. Q3 FY25 already hinted at this with flat volumes; Q4 profit relies heavily on margin expansion, not volume surge.[^6] [^6]: 6/ Procurement angle: Buyers of lab consumables like beakers, pipettes, should check distributor inventories. Distortions mean future price wars or shortages if excess stock floods market. PalwinderCFA urged teams to "watch inventory distortions at distributors" given solid headlines vs. softer demand.[^7] [^7]: 7/ Borosil context: The company dominates India's scientific glassware market (60%+ share), supplies labs, pharma, research institutes. FY25 capex of 500 million rupees targets capacity expansion to 100,000 tons annually by FY27. But if channel stuffing is real, distributor relationships could strain.[^8] [^8]: 8/ Stock reaction: Shares rose 5% intraday on May 20 to 285 rupees, but analysts like Motilal Oswal flagged inventory days at 120—elevated vs. peers. "Strong margins but watch working capital," their note said post-results.[^9] [^9]: 9/ What's next? Q1 FY26 results due late July 2026. Track distributor sales data via IndiaMART or trade reports. If returns spike or margins compress, confirms stuffing. Procurement: Audit channel partners now—ask for stock aging reports before reordering.[^10] [^10]: (distributor listings)